TriSalus Life Sciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WEALTHCARE ADVISORY PARTNERS LLC | 01/15/2025 | 643,740 | $3.23 M | 0.00% | 2.43% |
| DUQUESNE FAMILY OFFICE LLC | 02/14/2025 | 426,921 | $2.14 M | 0.00% | 1.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 204,137 | $1.02 M | 1.85% | 0.77% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 178,446 | $894,015 | 120,471.62% | 0.67% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 80,538 | $403,495 | -17.72% | 0.30% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 65,000 | $325,650 | 333.33% | 0.25% |
| MSD PARTNERS, L.P. | 02/14/2025 | 39,999 | $200,395 | 0.00% | 0.15% |
| NORTHERN TRUST CORP | 02/14/2025 | 32,112 | $160,881 | 22.68% | 0.12% |
| BLACKROCK, INC. | 02/07/2025 | 30,270 | $151,653 | 0.00% | 0.11% |
| CONNECTIVE CAPITAL MANAGEMENT, LLC | 02/18/2025 | 27,989 | $140,225 | 100.00% | 0.11% |
| VESTCOR INC | 02/10/2025 | 23,376 | $117,000 | 0.00% | 0.09% |
| CONNECTICUT WEALTH MANAGEMENT, LLC | 02/18/2025 | 22,303 | $111,738 | -32.17% | 0.08% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 15,554 | $78,000 | 0.00% | 0.06% |
| GILDER GAGNON HOWE & CO LLC | 02/14/2025 | 14,420 | $72,244 | -0.14% | 0.05% |
| LIDO ADVISORS, LLC | 02/14/2025 | 14,024 | $70,260 | -59.96% | 0.05% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 13,400 | $67,134 | 100.00% | 0.05% |
| ANGELO GORDON & CO., L.P. | 02/14/2025 | 10,854 | $54,379 | -47.95% | 0.04% |
| EXOS ASSET MANAGEMENT LLC | 02/13/2025 | 3,604 | $18,056 | -90.66% | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 02/03/2025 | 1,032 | $5,170 | -78.26% | 0.00% |
| HOERTKORN RICHARD CHARLES | 02/12/2025 | 668 | $3,347 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 555 | $2,781 | -67.41% | 0.00% |
| SIGNATUREFD, LLC | 02/10/2025 | 100 | $501 | 0.00% | 0.00% |
| MORGAN STANLEY | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MAGNETAR FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TriSalus Life Sciences, Inc. institutional Ownership - FAQ's
During the previous two years, 28 institutional investors and hedge funds held shares of TriSalus Life Sciences, Inc.. The most heavily invested institutionals were:
Duquesne Family Office LLC: 426,921
GEODE CAPITAL MANAGEMENT, LLC: 204,137
BANK OF AMERICA CORP /DE/: 178,446
MILLENNIUM MANAGEMENT LLC: 80,538
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 65,000
MSD Partners, L.P.: 39,999
8.77% of TriSalus Life Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.24 M shares in the last 24 months. This purchase volume represents approximately $6.82 M in transactions.